FROM CYCLOPHOSPHAMIDE HEMATOTOXICITY TO MODELING CANCER

E. Luebeck
DOI: https://doi.org/10.1080/00984100050166578
2000-11-01
Abstract:The cyclophosphamide hematotoxicity (CPH) model presented by Cox embodies several scientific concepts that are worth commenting on. Perhaps the most important issue is the merit and plausibility of the underlying biological assumptions and, connected to this, the question of how far the mathematical and computational framework of this model captures these assumptions. My comments focus mainly on mathematical and statistical aspects as they relate to the potential use of the model in benzene-induced leukemogenesis, for which the CPH model may serve as protype for modeling the possible carcinogenic effects of exposure to benzene. My comments, therefore, address mainly the usefulness of the present pharmacokinetic formulation of cyclophosphamide (CP)-induced cytotoxicity as it relates to modeling carcinogenesis. This includes reflecting upon the adequacy of deterministically formulated models versus stochastic models in describing the intermediate clonal expansion in carcinogenesis. General remarks concerning the statistical nature and usefulness of the CPH model are:
What problem does this paper attempt to address?